Clinical Trial Update: TNT to Increase the Clinical Complete Response Rate for Distal LARC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update aiming to increase clinical complete response rate for distal locally advanced rectal cancer (LARC) undergoing chemoradiation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rectal Cancer, Rectal Cancer Stage II | Phase 2 | Status: ACTIVE_NOT_RECRUITING